BRAF and neoplasm: Considering the current evidence of the association between LDL and tumor progression, and the effect of LDL on MAPK activation [37], we aimed to study the role of LDL in PTC cells and the connection with BRAF V600E mutation as a metabolic trigger of the tumor aggressiveness.